MedPath

Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions

Not Applicable
Completed
Conditions
Prostate Cancer
Registration Number
NCT03477591
Lead Sponsor
McMaster University
Brief Summary

Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by men facing prostate cancer screening decisions.

Detailed Description

Guidelines for prostate screening in Canada are based on low-moderate quality evidence of effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs) are tools that assist users to understand treatment options, risks and benefits to align decisions with values and preferences. The investigators would now like to know whether use of a PDA alongside evidence-based information provided through the McMaster Optimal Aging Portal, or simply access to evidence-based information alone, can help users to make informed decisions about prostate cancer screening in men.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
308
Inclusion Criteria
  • English speaking men, > 50 years old
Exclusion Criteria
  • History of prostate cancer or PSA test in the last 12 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Decisional conflictChange from baseline to 6-mo

Decisional Conflict Scale

Secondary Outcome Measures
NameTimeMethod
Decision qualityChange from baseline to 6-mo

Decision Quality Worksheet for PSA testing

Preparation for decision makingChange from baseline to 6-mo

Preparation for decision making scale

Screening behaviourChange from baseline to 6-mo

Congruency between self-reported screening status and stated decision

Trial Locations

Locations (1)

McMaster University

🇨🇦

Hamilton, Ontario, Canada

McMaster University
🇨🇦Hamilton, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.